ArticleThe Journal of international medical research2025
Postoperative incision metastasis of lung cancer: A case report.
Article in The Journal of international medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Incisional recurrence, also known as metastasis to the surgical scar, is a relatively rare but serious complication following the surgical resection of lung cancer. Herein, we report a case of postoperative incision metastasis of lung cancer. A 75-year-old Han Chinese male patient was admitted upon discovery of a chest wall mass during a routine physical examination 3 months ago. The patient underwent a radical resection of left lower lobe lung cancer 12 years ago. Notably, he experienced left chest pain and discomfort during a routine examination 12 years postoperatively, leading to the discovery of a chest wall mass measuring 3.5 cm × 2.1 cm × 4.2 cm at the original incision site. Ultrasound-guided core biopsy confirmed the pathological diagnosis of lung adenocarcinoma derived from the chest wall incision, and subsequent gene testing identified a SLC34A2-ROS1 (S4;R31) fusion gene mutation. After the patient underwent two cycles of chemotherapy, a re-examination of the chest computed tomography scan revealed that the mass on the chest wall had significantly shrunk. Subsequently, the patient underwent surgical resection of the chest wall mass. Postoperative pathology confirmed metastatic lung adenocarcinoma from the postoperative incision of lung cancer. The patient was discharged uneventfully and has not shown any obvious recurrence or metastasis during the 2-month follow-up. Improved prognosis of postoperative incisional metastasis of lung cancer is observed after timely comprehensive treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.